Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$728.7M
+66.8% from 2023
Prescriptions
30K
$24,031.51 per claim
Patients
4,384
1,322 prescribers
Total spending, 2024
$728.8M
$166,192.12 per patient
Medicare prescription drug plans paid $728.7M for Tyvaso Dpi in 2024, for 30,323 prescriptions and refills to 4,384 patients (up 66.8% from 2023). The average cost per claim was $24,031.51.
New York had the highest Medicare cost for Tyvaso Dpi in 2024: $54.7M for 2,312 claims, followed by California ($49.9M).
Vallerie V McLaughlin, cardiology in Ann Arbor, MI, had the highest Medicare cost for Tyvaso Dpi in 2024: 519 claims costing $12.6M.
Tyvaso Dpi is made by United Therapeutics Corporation (UTHR), listed in the Medicare spending data as United Therap.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Vallerie V McLaughlin Ann Arbor, MI | Cardiology | 519 | 65 | $12.6M |
| Eric G Roberts Milwaukee, WI | Advanced Heart Failure and Transplant Cardiology | 323 | 41 | $7.8M |
| Victor M Moles |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 489 | 3,424 | 1,141 | $78.2M |
| 2023 | 1,016 | 18,556 | 3,017 | $436.9M |
| 2024 | 1,322 | 30,323 | 4,384 | $728.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 272 |
| 34 |
| $6.7M |
| Timothy L Williamson Kansas City, KS | Pulmonary Disease | 262 | 30 | $6.3M |
| Ashwin K Ravichandran Indianapolis, IN | Advanced Heart Failure and Transplant Cardiology | 245 | 17 | $6.2M |
| Kimberly C Thompson Rochester, MN | Nurse Practitioner | 242 | 37 | $6.0M |
| Hunter C Champion Sr. Columbus, GA | Cardiology | 223 | 22 | $5.2M |
| John Kingrey Oklahoma City, OK | Pulmonary Disease | 205 | 25 | $4.9M |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 207 | 23 | $4.8M |
| Simone Hannah-Clark New York, NY | Nurse Practitioner | 194 | 39 | $4.8M |
| Thenappan Thenappan Minneapolis, MN | Advanced Heart Failure and Transplant Cardiology | 193 | 28 | $4.7M |
| Victor J Test Lubbock, TX | Pulmonary Disease | 179 | 28 | $4.4M |
| Hilamber Subba South Portland, ME | Internal Medicine | 185 | 22 | $4.4M |
| Kishan S Parikh Raleigh, NC | Advanced Heart Failure and Transplant Cardiology | 175 | 21 | $4.3M |
| Christina M Eagan Gainesville, FL | Nurse Practitioner | 178 | 17 | $4.2M |
| John W Swisher Knoxville, TN | Pulmonary Disease | 175 | 27 | $4.2M |
| Mary Whittenhall Attleboro, MA | Nurse Practitioner | 174 | 25 | $4.0M |
| Murali M Chakinala Saint Louis, MO | Pulmonary Disease | 155 | 13 | $3.9M |
| Shelley M Shapiro Los Angeles, CA | Cardiology | 147 | 15 | $3.8M |
| Aaron C Miller Columbia, MO | Pulmonary Disease | 151 | 17 | $3.7M |
| Muhyaldeen Dia Oak Lawn, IL | Advanced Heart Failure and Transplant Cardiology | 149 | 22 | $3.7M |
| Alvaro U Aranda- Rodriguez Guaynabo, PR | Pulmonary Disease | 159 | 21 | $3.7M |
| Benjamin D Wind Philadelphia, PA | Pulmonary Disease | 149 | 23 | $3.6M |
| Gregg M Lanier Hawthorne, NY | Advanced Heart Failure and Transplant Cardiology | 153 | 21 | $3.5M |
| Robert J Schilz Cleveland, OH | Pulmonary Disease | 141 | Under 11 | $3.4M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| United Therap UTHR | 30,325 | $728.8M |